🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
Axis Capital Initiates Zomato Coverage With ‘Buy’, Calls It A ‘Compelling Investment Opportunity’
Inc42
·
1y ago
Medial
Axis brokerage has set a price target of INR 254 for Zomato, implying a potential upside of 36%. Despite slow growth in Zomato's food delivery sector, Axis expects its market share to increase to 54%, resulting in a compound annual growth rate (CAGR) of 16% by FY30. In the quick commerce sector, Axis predicts Blinkit's gross order value (GOV) to experience a CAGR of 38% from FY24 to FY30, reaching $10.5 billion.
View Source
Related News
Analysts initiates coverage on this Jhunjhunwala stock; see upto 80% uspide
Business Today
·
4m ago
Medial
Domestic brokerage firms Nuvama and JM Financial have initiated coverage on a recently-listed stock linked to famed investor Jhunjhunwala, projecting an upside potential of up to 80%. This suggests strong market confidence and anticipated growth, highlighting the stock as a notable investment opportunity. The coverage by reputable firms underscores the potential value increase, catching the attention of investors seeking promising stocks in the market with substantial returns.
View Source
ICICI Securities Initiates Coverage On Honasa With ‘BUY’ Rating, Sees 28% Upside
Inc42
·
1y ago
Medial
ICICI Securities has initiated coverage on Honasa Consumer Ltd, the parent company of Mamaearth, with a ‘BUY’ rating and a price target of INR 550 per share. The brokerage believes that Honasa's agile and low-risk business model, along with its digital-first approach, positions it well in the beauty and personal care industry. Honasa's portfolio of brands, including Mamaearth, The Derma Co, and others, is expected to benefit from industry growth. While the report highlights challenges in scaling offline distribution and the limitations of a niche natural ingredient-oriented approach, Honasa's newer brands are experiencing strong growth. Shares of Honasa have surged since listing on the stock exchanges in November last year.
View Source
Citi Initiates Coverage On Mamaearth With ‘Buy’ Rating, Sees 24% Upside
Inc42
·
1y ago
Medial
Mamaearth's parent company, Honasa Consumer Ltd, has received a 'buy' rating from brokerage firm Citi Research. Citi expects the company to outperform in terms of growth due to its strong brand positioning and market opportunity. It has set a price target for Honasa of INR 550, representing a potential upside of 24%. The brokerage also noted that Honasa's innovative products, expansion into new categories, and margin expansion are positive factors for its long-term success. Mamaearth saw a 264% increase in net profit in Q3 FY24, with its revenue expected to grow at a 25% CAGR over the FY24-FY26 period.
View Source
Investec initiates coverage on Stylam Industries with buy call, sees 41% upside
Money Control
·
1y ago
Medial
Shares of Stylam Industries surged around nine percent following coverage initiation by Investec with a 'buy' rating and a target price of Rs. 2,362, implying a 41 percent upside. Investec mentioned the rapid revenue growth of Stylam in both domestic and export markets, highlighting the company's strong execution and distribution strategies. Stylam Industries has delivered consistent revenue growth and has outperformed peers on operating metrics, benefiting from cost control measures. The company could witness a 19 percent CAGR in EBITDA over FY24-26E.
View Source
Shiprocket planning for a ₹2,500-crore IPO in 2025: Report
Inshorts
·
8m ago
Medial
Zomato and Temasek-backed logistics-tech unicorn Shiprocket is planning to launch an IPO in 2025 to raise ₹2,000-₹2,500 crore, Moneycontrol reported. "Work on the deal has begun...Axis Capital, Kotak Mahindra Capital, JM Financial and BofA Securities are the investment banks acting on the issue," sources cited by the report said.
View Source
Now, Zomato Initiates ITR Filing For Its Delivery Partners
Inc42
·
1y ago
Medial
Zomato announced that it paid over INR 4,000 Cr to delivery partners last year, with INR 40 Cr withheld as TDS. Within a few days of launching the Zomato Delivery Partner app, more than 100,000 partners have started filing their income tax returns. Zomato's stock closed slightly lower at INR 218.80 on Friday.
View Source
Axis Bank won't infuse more capital into NBFC; it will tap market
Economic Times
·
1m ago
Medial
Axis Bank has pledged to the Reserve Bank of India that it will not inject new capital into Axis Finance, its finance company. Instead, Axis Finance plans to raise ₹3,000 crore through an IPO. This move aligns with RBI's guidelines, which discourage banks from overlapping business operations with their subsidiaries. Axis Finance aims to raise market capital without involving Axis Bank, ensuring compliance with regulatory directives while pursuing growth strategies.
View Source
Shiprocket to soon file confidential prospectus for Rs 2,000-2,500 crore IPO
Economic Times
·
2m ago
Medial
Zomato-backed Shiprocket plans to file a confidential draft prospectus with Sebi for a Rs 2,000-2,500 crore IPO. The ecommerce logistics firm aims to raise Rs 1,000-1,200 crore in fresh capital. Shiprocket has grown 20-25% in FY25 despite a challenging ecommerce landscape, serving mostly tier-II and tier-III cities. It has expanded its focus to payments, cross-border shipping, and quick commerce while acquiring several companies. The IPO is being managed by Axis Capital, Kotak Mahindra, JM Financial, and Bank of America.
View Source
Axis Capital ropes in former JM Financial executive as MD, CEO
VCCircle
·
1y ago
Medial
Axis Capital, an investment bank, has appointed Atul Mehra as the managing director and chief executive officer. With over three decades of experience in the equity capital market and mergers and acquisitions, Mehra will oversee the investment banking and institutional equities businesses. The bank has seen multiple departures at the top level in recent months. Mehra's appointment comes after Salil Pitale and Chirag Negandhi left the firm as co-heads in the past few months. Axis Capital has also appointed Parag Gude and Dhaval Desai in key positions.
View Source
Investing in the Growth Story of Indian Pharma
StartupTalky
·
1y ago
Medial
The Indian pharmaceutical industry presents a compelling investment opportunity due to its strong fundamentals, robust exports, and government support. Major Indian pharma companies have delivered impressive stock market performances, driven by rising domestic demand, strong exports, and innovation in research and development. However, investors must be aware of potential risks such as regulatory scrutiny, currency fluctuations, and competition. To make informed investment decisions, it is important to analyze company fundamentals, product portfolios, market focus, regulatory compliance, and management expertise. Emerging trends in the industry include the focus on specialty drugs, contract research and manufacturing services, and digital transformation. Despite challenges, the Indian pharma sector offers a promising investment landscape with long-term growth prospects.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
June 2025
Buddy
Helping your parents when you are miles away
BiteStop
The Pit Stop Your Cravings Deserve
Bloomer
The next generation E-commerce platform
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in